Figure 4
Percentages of apoptotic CP-18821 Barrett's esophagus-derived cells after treatment with FXR (4A) or VDR (4B) ligands, as measured by flow cytometry.
Figure 4 | Molecular Cancer
Percentages of apoptotic CP-18821 Barrett's esophagus-derived cells after treatment with FXR (4A) or VDR (4B) ligands, as measured by flow cytometry.
Molecular Cancer